FDA.reportPublic FDA data

SHELLAC

Substance profile for UNII 46N107B71O, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
46N107B71O
Preferred term
SHELLAC
Registry number
9000-59-3
EC number
232-549-9
Ingredient type
INGREDIENT SUBSTANCE

Chemical And Database Identifiers#

RxCUI
1368898
PubChem
0
NCIt
C66001
INN ID
0
NCBI
473130

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1368898https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1368898
NCI ThesaurusC66001https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C66001
FDA Substance Registration System46N107B71Ohttps://precision.fda.gov/uniisearch/srs/unii/46N107B71O
European Community number232-549-9https://commonchemistry.cas.org/results?q=232-549-9

Legacy UNII Aliases#

Legacy UNII, Term, Last update table
Legacy UNIITermLast update
46N107B71OSHELLAC2019-03-18 19:36:14

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use tamsulosin hydrochloride capsules safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. TAMSULOSIN hydrochloride capsules USP, 0.4 mg for oral use Initial U.S. Approval: 19976
SHELLACINACTIVE INGREDIENT46N107B71OLANSOPRAZOLE7
ShellacINACTIVE INGREDIENT46N107B71OPANTOPRAZOLE SODIUM5
SHELLACINACTIVE INGREDIENT46N107B71OTerazosin Capsules, USP10
SHELLACINACTIVE INGREDIENT46N107B71OTerazosin Hydrochloride Capsules9
SHELLACINACTIVE INGREDIENT46N107B71OChlorpromazine Hydrochloride Tablets, USP5
ShellacINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use esomeprazole magnesium safely and effectively. See full prescribing information for esomeprazole magnesium. Esomeprazole magnesium delayed-release capsules USP, for oral use Initial U.S. Approval: 1989 (omeprazole)6
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use duloxetine delayed-release capsules, USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules, USP. DULOXETINE delayed-release capsules USP, for oral use. Initial U.S. Approval: 20047
SHELLACINACTIVE INGREDIENT46N107B71OIndomethacin Capsules USP, 25 mg and 50 mg5
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use tacrolimus capsules safely and effectively. See full prescribing information for tacrolimus capsules. TACROLIMUS Capsules, USP for oral use Initial U.S. Approval: 19946
SHELLACINACTIVE INGREDIENT46N107B71OBENZONATATE CAPSULES, USP Rx Only5
SHELLACINACTIVE INGREDIENT46N107B71OIndomethacin Extended – Release Capsules, USP 75 mg5
SHELLACINACTIVE INGREDIENT46N107B71Oc635af0d-b005-4bce-8c43-24d0508c28ad5
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. OMEPRAZOLE Delayed-Release Capsules USP Initial U.S. Approval: 19895
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use PANTOPRAZOLE sodium delayed-release tablets, USP safely and effectively. See full prescribing information for PANTOPRAZOLE sodium delayed-release tablets, USP. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral administration Initial U.S. approval: 200011
SHELLACINACTIVE INGREDIENT46N107B71OGABAPENTIN CAPSULES, USP5
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 198915
SHELLACINACTIVE INGREDIENT46N107B71OVENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP 7384 7385 7386 Rx only7
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use fluoxetine capsules, USP safely and effectively. See full prescribing information for fluoxetine capsules, USP. FLUOXETINE Capsules, USP for Oral Use Initial U.S. Approval: 19874
SHELLACINACTIVE INGREDIENT46N107B71ONITROFURANTOIN CAPSULES USP (Macrocrystals) Rx only 2130 21311002
SHELLACINACTIVE INGREDIENT46N107B71ODRUG FACTS1001
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20001001
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use amlodipine besylate and benazepril hydrochloride capsules safely and effectively. See full prescribing information for amlodipine besylate and benazepril hydrochloride capsules. AMLODIPINE besylate and BENAZEPRIL hydrochloride capsules for oral use Initial U.S. Approval: 19951000
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use Omeprazole delayed-release capsules safely and effectively. See full prescribing information for Omeprazole delayed-release capsules. OMEPRAZOLE delayed-release capsules, USP, for oral use Initial U.S. Approval: 198923
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use amlodipine besylate and benazepril hydrochloride capsules safely and effectively. See full prescribing information for amlodipine besylate and benazepril hydrochloride capsules. Amlodipine Besylate and Benazepril Hydrochloride Capsules Initial U.S. Approval: 19951001
ShellacINACTIVE INGREDIENT46N107B71OCEPHALEXIN CAPSULES, USP8
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use fluoxetine capsules, USP safely and effectively. See full prescribing information for fluoxetine capsules, USP. FLUOXETINE Capsules, USP for Oral Use Initial U.S. Approval: 198715
SHELLACINACTIVE INGREDIENT46N107B71OGABAPENTIN CAPSULES, USP Rx only5
SHELLACINACTIVE INGREDIENT46N107B71OCLARAVIS™ (isotretinoin capsules USP)4
SHELLACINACTIVE INGREDIENT46N107B71OLITHIUM CARBONATE Tablets USP LITHIUM CARBONATE Capsules USP LITHIUM Oral Solution USP13
SHELLACINACTIVE INGREDIENT46N107B71OZonisamide Capsules11
SHELLACINACTIVE INGREDIENT46N107B71OGABAPENTIN CAPSULES, USP 40-9155 Revised — September 2011 Rx only27
SHELLACINACTIVE INGREDIENT46N107B71Oc70b5045-706e-443a-9be1-d0bc3c5981304
SHELLACINACTIVE INGREDIENT46N107B71OBisacodyl Enteric Coated Tablet7
SHELLACINACTIVE INGREDIENT46N107B71OTerazosin Hydrochloride Capsules6
SHELLACINACTIVE INGREDIENT46N107B71OVENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 7384 7385 7386 Rx only6
SHELLACINACTIVE INGREDIENT46N107B71OVerapamil Hydrochloride Sustained-Release Capsules1000
SHELLACINACTIVE INGREDIENT46N107B71O80b7007e-be26-4388-8d62-9541baf75c6b1000
shellacINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use phentermine hydrochloride tablets USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets USP. PHENTERMINE Hydrochloride Tablets USP CIV for oral use Initial U.S. Approval: 19595
SHELLACINACTIVE INGREDIENT46N107B71OHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP "Initial U.S. Approval:".19896
SHELLACINACTIVE INGREDIENT46N107B71Od6a161d9-7e7a-4711-ba0e-c9040c42268d5
SHELLACINACTIVE INGREDIENT46N107B71Ob3180408-a3c0-4e02-8535-dea390a522777
SHELLACINACTIVE INGREDIENT46N107B71OTriamterene and Hydrochlorothiazide Capsules, USP6
SHELLACINACTIVE INGREDIENT46N107B71OChlorpromazine Hydrochloride Tablets, USP4
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use Amlodipine Besylate and Benazepril Hydrochloride Capsules safely and effectively. See full prescribing information for Amlodipine Besylate and Benazepril Hydrochloride Capsules. Amlodipine Besylate and Benazepril Hydrochloride Capsules Initial U.S. Approval: 19955
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 20045
SHELLACINACTIVE INGREDIENT46N107B71OAmoxicillin Capsules, Tablets and Powder for Oral Suspension, USP6
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use lansoprazole delayed-release capsules USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules USP. LANSOPRAZOLE delayed-release capsules USP for oral use Initial U.S. Approval: 19954
SHELLACINACTIVE INGREDIENT46N107B71OLithium Carbonate Capsules USP Rx Only6
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 20043362
SHELLACINACTIVE INGREDIENT46N107B71OIndomethacin Extended – Release Capsules, USP 75 mg3231
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use fluoxetine capsules USP safely and effectively. See full prescribing information for fluoxetine capsules USP. Initial U.S. Approval: 19879
SHELLACINACTIVE INGREDIENT46N107B71OStrazepam17
SHELLACINACTIVE INGREDIENT46N107B71OFluoxetine 10 mg These highlights do not include all the information needed to use fluoxetine capsules USP safely and effectively. See full prescribing information for fluoxetine capsules USP. Initial U.S. Approval: 19879
SHELLACINACTIVE INGREDIENT46N107B71OFluoxetine 10 mg These highlights do not include all the information needed to use fluoxetine capsules USP safely and effectively. See full prescribing information for fluoxetine capsules USP. Initial U.S. Approval: 19878
SHELLACINACTIVE INGREDIENT46N107B71OHYDROXYZINE PAMOATE Capsules USP5
SHELLACINACTIVE INGREDIENT46N107B71OAMOXICILLIN CAPSULES USP, 250 mg and 500 mg/ AMOXICILLIN FOR ORAL SUSPENSION USP, 125 mg per 5 mL and 250 mg per 5 mL/AMOXICILLIN TABLETS USP (CHEWABLE), 125 mg and 250 mg 3107 3109 2267 2268 4150 4155 Rx only10
SHELLACINACTIVE INGREDIENT46N107B71OThese highlights do not include all the information needed to use Calcium Acetate Capsules safely and effectively. See full prescribing information for Calcium Acetate Capsules. Calcium Acetate Capsules, 667 mg Initial U.S. Approval: 19907
SHELLACINACTIVE INGREDIENT46N107B71OLYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY, DBA QUALITY CARE PRODUCTS, LLC]3996
SHELLACINACTIVE INGREDIENT46N107B71ODIVALPROEX SODIUM DR (DIVALPROEX SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3983
SHELLACINACTIVE INGREDIENT46N107B71OFLUOXETINE (FLUOXETINE HYDROCHLORIDE) CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3978
shellacINACTIVE INGREDIENT46N107B71OTEMAZEPAM CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3945
SHELLACINACTIVE INGREDIENT46N107B71ONITROFURANTOIN (MACROCRYSTALS) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3922
SHELLACINACTIVE INGREDIENT46N107B71OINDOMETHACIN CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3911
SHELLACINACTIVE INGREDIENT46N107B71OMEXILETINE HYDROCHLORIDE CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3749
SHELLACINACTIVE INGREDIENT46N107B71ODICLOFENAC SODIUM DELAYED RELEASE (DICLOFENAC SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3744
SHELLACINACTIVE INGREDIENT46N107B71OOMEPRAZOLE CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3741
SHELLACINACTIVE INGREDIENT46N107B71ONITROFURANTOIN MACROCRYSTALS CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3740
SHELLACINACTIVE INGREDIENT46N107B71ODOXEPIN HYDROCHLORIDE CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3724
SHELLACINACTIVE INGREDIENT46N107B71OLYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3671
SHELLACINACTIVE INGREDIENT46N107B71OETODOLAC CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALTIY CARE PRODUCTS LLC]3619
SHELLACINACTIVE INGREDIENT46N107B71ODOXEPIN HYDROCHLORIDE CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3616
SHELLACINACTIVE INGREDIENT46N107B71OTEMAZEPAM CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3561
SHELLACINACTIVE INGREDIENT46N107B71OLYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3544
SHELLACINACTIVE INGREDIENT46N107B71OLYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3535
SHELLACINACTIVE INGREDIENT46N107B71OINDOMETHACIN CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3369
SHELLACINACTIVE INGREDIENT46N107B71OLYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3363
SHELLACINACTIVE INGREDIENT46N107B71OTRAMADOL HYDROCHLORIDE (TRAMADOL HYDROCHLORIDE) TABLET, EXTENDED RELEASE TRAMADOL HYDROCHLORIDE (TRAMADOL HYDROCHLORIDE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3040
SHELLACINACTIVE INGREDIENT46N107B71OFLUOXETINE (FLUOXETINE HYDROCHLORIDE) CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3024
SHELLACINACTIVE INGREDIENT46N107B71ODIVALPROEX SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1005
SHELLACINACTIVE INGREDIENT46N107B71ODOXEPIN HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK]1002
SHELLACINACTIVE INGREDIENT46N107B71OTRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1002
SHELLACINACTIVE INGREDIENT46N107B71OCHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK]1001
SHELLACINACTIVE INGREDIENT46N107B71OLOPERAMIDE HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK]1001
SHELLACINACTIVE INGREDIENT46N107B71OLYRICA (PREGABALIN) CAPSULE [BRYANT RANCH PREPACK]1001
SHELLACINACTIVE INGREDIENT46N107B71OLYRICA (PREGABALIN) CAPSULE [BRYANT RANCH PREPACK]1001
SHELLACINACTIVE INGREDIENT46N107B71ONORTRIPTYLINE HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK]1001
SHELLACINACTIVE INGREDIENT46N107B71OVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1001
SHELLACINACTIVE INGREDIENT46N107B71OAFEDITAB CR (NIFEDIPINE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71ODOXEPIN HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71ODULOXETINE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71ODULOXETINE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OGLIPIZIDE ER (GLIPIZIDE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OIBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE TABLET, SUGAR COATED [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OKADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OKADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OLANSOPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OLORATADINE AND PSEUDOEPHEDRINE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OLYRICA (PREGABALIN) CAPSULE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OLYRICA (PREGABALIN) CAPSULE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OLYRICA (PREGABALIN) CAPSULE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71ONASAL DECONGESTANT (PSEUDOEPHEDRINE HCL) TABLET, SUGAR COATED [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OPHENTERMINE HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OPHENTERMINE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71OVERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
SHELLACINACTIVE INGREDIENT46N107B71ODOXEPIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC. ]166
SHELLACINACTIVE INGREDIENT46N107B71OFLUOXETINE HYDROCHLORIDE CAPSULE [REMEDYREPACK INC. ]162
SHELLACINACTIVE INGREDIENT46N107B71ODOXEPIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC. ]155
SHELLACINACTIVE INGREDIENT46N107B71OCHLORPROMAZINE HYDROCHLORIDE TABLET, SUGAR COATED [REMEDYREPACK INC. ]151
SHELLACINACTIVE INGREDIENT46N107B71OCHLORPROMAZINE HYDROCHLORIDE TABLET, SUGAR COATED [REMEDYREPACK INC. ]150
SHELLACINACTIVE INGREDIENT46N107B71ODOXEPIN HYDROCHLORIDE (DOXEPIN HYDROCHLORIDE) CAPSULE [REMEDYREPACK INC. ]145
SHELLACINACTIVE INGREDIENT46N107B71ODOXEPIN HYDROCHLORIDE (DOXEPIN HYDROCHLORIDE) CAPSULE [REMEDYREPACK INC. ]126
SHELLACINACTIVE INGREDIENT46N107B71OINDOMETHACIN (INDOMETHACIN) CAPSULE [REMEDYREPACK INC. ]125
SHELLACINACTIVE INGREDIENT46N107B71OCALCIUM ACETATE (CALCIUM ACETATE) CAPSULE [REMEDYREPACK INC. ]79
SHELLACINACTIVE INGREDIENT46N107B71OTERAZOSIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC. ]77
SHELLACINACTIVE INGREDIENT46N107B71ODEXMETHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]36
SHELLACINACTIVE INGREDIENT46N107B71OVICTRELIS (BOCEPREVIR) CAPSULE [MERCK SHARP & DOHME CORP.]33

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 46N107B71O page 1 of 1 · 13 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
SHELLAC46N107B71O9000593CAPSULEORAL34.48 mg
SHELLAC46N107B71O9000593CAPSULE, COATED PELLETSORAL29 mg
SHELLAC46N107B71O9000593CAPSULE, COATED, EXTENDED RELEASEORALNA
SHELLAC46N107B71O9000593CAPSULE, DELAYED RELEASEORAL1 mg
SHELLAC46N107B71O9000593CAPSULE, EXTENDED RELEASEORAL75.01 mg
SHELLAC46N107B71O9000593SUSPENSIONORAL3 mg/1ml
SHELLAC46N107B71O9000593TABLETORAL112 mg
SHELLAC46N107B71O9000593TABLET, COATEDORAL30 mg
SHELLAC46N107B71O9000593TABLET, DELAYED RELEASEORAL8 mg
SHELLAC46N107B71O9000593TABLET, EXTENDED RELEASEORAL213.24 mg
SHELLAC46N107B71O9000593TABLET, FILM COATEDORAL4.4 mg
SHELLAC46N107B71O9000593TABLET, SUGAR COATEDORALNA
SHELLAC46N107B71O9000593FILMSUBLINGUALNA